Single-dose rasburicase for tumour lysis syndrome in adults: weight-based approach.
about
Pegloticase for chronic goutRecognizing and managing the expanded risk of tumor lysis syndrome in hematologic and solid malignanciesRasburicase in the management of tumor lysis: an evidence-based review of its place in therapySupportive medical care for children with acute lymphoblastic leukemia in low- and middle-income countries.A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome.The optimal single-dose regimen of rasburicase for management of tumour lysis syndrome in children and adults: a systematic review and meta-analysis.One for the road! A study to assess the efficacy of single low-dose regimen of rasburicase in controlling hyperuricaemia in patients with tumour lysis syndrome due to haematological malignancies.Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase.Fixed-dose rasburicase 6 mg for hyperuricemia and tumor lysis syndrome in high-risk cancer patients.A review of tumour lysis syndrome with targeted therapies and the role of rasburicase.Comparative evaluation of single fixed dosing and weight-based dosing of rasburicase for tumor lysis syndrome.Enzymes approved for human therapy: indications, mechanisms and adverse effects.Tumor lysis syndrome: A clinical review.Analysis of the incidence of tumor lysis syndrome in patients with hematological malignancies treated with rasburicase.Economic implications of rasburicase treatment in adult patients with tumour lysis syndrome.Managing tumor lysis syndrome in 2010.Designing a mutant Candida uricase with improved polymerization state and enzymatic activity.Efficacy and cost of single-dose rasburicase in prevention and treatment of adult tumour lysis syndrome: a meta-analysis.Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco-HématologiqueTumour lysis syndrome in children: experience of last decade
P2860
Q24236711-5943FB96-1639-4BE1-8716-76E4C3E2C2FAQ26862904-C61FC623-D70A-4635-8AA5-0B55CC0DBE35Q28082089-5B566337-DC06-4E54-AAF2-050E10923C5DQ33423131-4CC53512-E9A4-440A-83F4-1D6167713DC0Q33947841-A55380C2-4D36-40D6-A5A0-1164E845BB56Q36204470-9359A615-A3DE-4950-A0E2-A7B6DDDFB046Q37372898-270F88DD-5AA8-4917-A728-A1DC19B287D9Q37629599-F17C140F-3ADB-460D-ADA2-1874AE008EBFQ37788882-41FB96FF-7F8A-4AC0-9533-9B0DCB78DD9DQ37866341-7DD2B0D2-1B41-4333-8049-EFF0F981B1FAQ38086143-B24AAE7A-F5F5-4D64-ADDB-FC759303B87BQ38342838-77E5C2CE-8E9C-4D70-BADC-3986B9FD4D13Q38457033-5963B35B-5D7C-4120-B1D9-726B63B2301AQ38739502-F7983AAF-745A-4300-950E-30DD5C6D1DADQ40065094-84DDE1A4-C174-423F-8602-06DD96873FBDQ43881802-25608A07-3C29-4335-B731-685FB24C82E8Q46257023-316E5993-6C04-48B1-B575-79A6495CC505Q46599361-D66314AD-A13B-420F-A123-3D6BFCC15141Q56968046-D2F4F672-153B-4B73-B214-F3459371232DQ57226051-7BAD4771-03AC-40B7-B407-FC001C3C9F48
P2860
Single-dose rasburicase for tumour lysis syndrome in adults: weight-based approach.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Single-dose rasburicase for tumour lysis syndrome in adults: weight-based approach.
@en
Single-dose rasburicase for tumour lysis syndrome in adults: weight-based approach.
@nl
type
label
Single-dose rasburicase for tumour lysis syndrome in adults: weight-based approach.
@en
Single-dose rasburicase for tumour lysis syndrome in adults: weight-based approach.
@nl
prefLabel
Single-dose rasburicase for tumour lysis syndrome in adults: weight-based approach.
@en
Single-dose rasburicase for tumour lysis syndrome in adults: weight-based approach.
@nl
P2093
P1476
Single-dose rasburicase for tumour lysis syndrome in adults: weight-based approach.
@en
P2093
P304
P356
10.1111/J.1365-2710.2008.00994.X
P577
2009-04-01T00:00:00Z